5 minute read

FEBRUARY 19, 2025

Register for the AIRA 2025 National Meeting

Don’t wait! Register before Sunday, March 2, and receive the early bird registration rate. This year, the AIRA 2025 National Meeting kicks off a day early on Monday with a dynamic opening plenary, educational workshops, and a lively networking reception to set the tone for the week. The AIRA room block is filling up quickly so be sure to reserve your hotel room soon!

Join us to explore the latest in IIS, reconnect with colleagues, and soak in Spokane’s scenic views and vibrant city charm.

We can’t wait to see you there! 🌲

Join us on Monday, February 24, from 4 to 5 p.m. ET for an engaging Discovery Session where we will explore how California is leveraging immunization data to estimate influenza vaccine effectiveness. This exciting session, led by the California Department of Public Health (CDPH), will dive into the findings from its first year using mandatory reporting for influenza testing and vaccinations to assess vaccine effectiveness for the 2023–2024 flu season.

This presentation will cover:

• Insights from California’s data on flu vaccine effectiveness
• Methodology and tools behind linking flu test results with vaccination data
• Challenges and lessons learned along the way

Take advantage of this unique opportunity to learn from California’s experience and join in a lively Q&A discussion following the presentation!

Once registered, you’ll receive a confirmation email with calendar links for easy access. If you can’t make it, a recording will be available in the AIRA Repository. We hope you’ll join us on February 24!

Please join us for the Power BI User Group on February 25, from noon to 1 p.m. ET for an exciting new demo from NYC displaying their Provider Quality Reports and HL7 Activity Dashboard created with Grafana. Join the Power BI User Group today!

AIRA, en colaboración con SYADEM, se complace en invitarte a la primera reunión de la Iniciativa del Codificación Internacional de Vacunas (IVC) completamente en español. Este evento inaugural en línea, de una hora de duración, está diseñado para profesionales que trabajan con codificación de vacunas o están interesados en ellos. Contará con la participación de ponentes de Estados Unidos y redes asociadas de América Latina, incluyendo el Centro de Monitoreo de Uppsala, creando una plataforma colaborativa para compartir conocimientos y establecer conexiones.

¿Qué puedes esperar?

• Introducción a los conjuntos de códigos de vacunas, incluyendo SNOMED e ICD-11
• Espacio de diálogo para compartir experiencias y enfoques en la codificación de vacunas a nivel internacional

Detalles del evento:

• Fecha: Miércoles, 12 de marzo
• Hora: 9 a.m. (ET) / 8 a.m. (Ciudad de México y Centroamérica) / 11 a.m. (Buenos Aires)
• Lugar: Virtual (Zoom)
• Idioma: Español

¡Reserva tu lugar hoy y únete a nosotros para dar forma al futuro de este esfuerzo internacional!

You Are Invited to the First Meeting of the International Vaccine Coding (IVC) Initiative Completely in Spanish!

AIRA, in collaboration with SYADEM, is pleased to invite you to the first meeting of the International Vaccine Coding (IVC) Initiative completely in Spanish. This inaugural hour-long online event is designed for professionals working with or interested in vaccine coding. It will feature speakers from the United States and associated networks in Latin America, including the Uppsala Monitoring Centre, creating a collaborative platform to share knowledge and establish connections.

What can you expect?

• Introduction to vaccine code sets, including SNOMED and ICD-11
• Space for dialogue to share experiences and approaches in vaccine coding at an international level

Event details:

• Date: Wednesday, March 12
• Time: 9 a.m. (ET) / 8 a.m. (Mexico City and Central America) / 11 a.m. (Buenos Aires)
• Location: Virtual (Zoom)
• Language: Spanish

Reserve your spot today and join us in shaping the future of this international effort!

AIRA members can submit and review information requests—a circulation of questions to and answers from the community. To submit an information request to the IIS community, email This email address is being protected from spambots. You need JavaScript enabled to view it. with “Information Request” in the subject line. Anyone who provides a meaningful response to an information request will be entered into a raffle to win a $25 gift card and will be recognized during the AIRA 2025 National Meeting awards ceremony. 

Open Information Requests

• The Washington State Department of Health (DOH) is seeking information regarding IIS handling of polio unspecified (CVX 89). As an unspecified CVX code, CVX 89 may represent any formulation of the polio vaccine. However, receipt of certain formulations (OPV monovalent, bivalent, and unspecified) may leave a patient under-vaccinated for polio. Among the OPV formulations, only the OPV trivalent formulation administered on or after 4/1/2016 is considered valid for completion of U.S. polio recommendations. Given this, Washington’s DOH would like answers to the following questions:
  
  How does your IIS treat CVX 89 in relation to the completion of U.S. polio recommendations? In other words, does your IIS consider a CVX 89 as counting toward the completion of the polio series, or does your IIS consider it invalid toward the completion of the polio series?
  
  Does your IIS follow up on submitted reports of CVX 89 and map the CVX 89 to a more specific polio CVX code? If so, what information is used to determine what CVX code to map to?
  
  Does your IIS make different decisions if you know CVX 89 was administered outside of the United States versus inside?
  
  If you are willing to share, please reach out to Katherine Graff at This email address is being protected from spambots. You need JavaScript enabled to view it. and copy This email address is being protected from spambots. You need JavaScript enabled to view it. by today, February 19. Don’t forget to include your contact information for follow-up.
  
  
• The Kentucky Department for Public Health is seeking information regarding user access for health plan users. Do you allow users from insurance companies (health plans, managed care organizations) to search for patients individually in your IIS? In other words, do users associated with health plans/insurance companies/managed care organizations have the ability to log into your IIS web application to look up individual patient records?
  
  

  If you are willing to share any relevant information, please respond to Laura Barrett at This email address is being protected from spambots. You need JavaScript enabled to view it. and copy This email address is being protected from spambots. You need JavaScript enabled to view it. by March 5. Don’t forget to include your contact information for follow-up.

Information requests are viewable only by individual members and individuals affiliated with member and partner organizations. Recent information requests can be found by using the “Information Requests” filter in the AIRA Repository. Just log in to view these valuable resources! If you have any questions, please email This email address is being protected from spambots. You need JavaScript enabled to view it..

BACK TO TOP

IIS technology partner product testing and validation through Measurement and Improvement (M&I) has been available since 2020. Product testing and validation provides IIS technology partners with an objective, independent testing process for their base product or modular component. The available data enables IIS technology partners to share their progress toward meeting national standards with the broader IIS community. The results can be shared with current and potential IIS customers and/or used to make enhancements to further align with standards.

In November 2024, the Measurement for Assessment and Certification Advisory Workgroup (MACAW) approved product testing and validation updates. IIS technology partner products are now eligible to receive Validation status at the complete level only if they opt into Validation. To reflect this change, the Aggregate Analysis Reporting Tool (AART) will display only complete levels of Validation for IIS technology partner products.

If IIS technology partners have questions, please submit a request using the TA Request Form or email This email address is being protected from spambots. You need JavaScript enabled to view it..

To learn more about IIS technology partner product testing and validation, check out these resources in the Repository:

• IIS Technology Partner Product Testing and Validation Summary 
• IIS Measurement and Improvement – IIS Technology Partner Product Testing and Validation FAQ

In July 2023, AIRA and the Measurement for Assessment and Certification Advisory Workgroup (MACAW) introduced two new measurable concepts to Testing and Discovery (T&D) as part of the Measurement and Improvement (M&I) initiative, Patient Matching–HL7 Submission and Patient Matching–HL7 Query. These measurable concepts focus on assessing the ability of an IIS to accurately match and consolidate patient records with variations in key fields such as name and address, enhancing health data interoperability.

Community Engagement and Finalized Measures

Building on outcomes from the first stage of the M&I initiative, Testing and Discovery, MACAW proposed over 200 measures and tests in fall 2024 for community input as a step toward advancing these areas to the second stage of the M&I initiative, Assessment. Through a robust feedback process, including a three-week comment period (November 4–26) and a community town hall (November 18), AIRA gathered 37 comments from seven groups. After thorough review and deliberation, MACAW finalized the measures and tests in early January 2025.

The finalized measures and tests are now published and available on AIRA’s Repository.

Updated Participation Settings in AART

AIRA has updated participation and sharing settings in AART for all IIS based on their settings for Testing and Discovery. IIS programs are encouraged to review and confirm their participation settings in AART to fully engage with these content areas in the new stage of Assessment.

Initial Assessment Reports: Coming Soon

Initial Assessment reports for participating IIS programs will be available in AART by March 31. These reports will establish a community baseline and provide valuable insights to inform ongoing improvements.

As AIRA and MACAW move forward, your feedback on the methodology, test case scenarios and expectations, and testing results remains critical. This input helps shape the future of the M&I initiative and ensures continuous improvement.

For questions or assistance or to provide feedback, please contact us at This email address is being protected from spambots. You need JavaScript enabled to view it. or for technical assistance, submit a request via the TA Request Form.

When setting the default view for your Power BI report, focus on displaying the most relevant data for your audience. Avoid selecting a broad range of data as it may not be useful and can cause longer initial load times. Remember, users can always drill down or up to explore more details, but the initial load time impacts every user, so keeping it concise ensures a faster and smoother experience.

BACK TO TOP

BACK TO TOP

American Immunization Registry Association
1717 Pennsylvania Avenue NW
Suite 1025 
Washington, DC 20006

© Copyright 2023, American Immunization Registry Association